Yuval Cohen

Insider Reports History

Reporting-owner location: Norwood, MA
Latest reporting-owner signature: /s/Yuval Cohen
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Yuval Cohen

Form 4 holding Chief Executive Officer, Director

Corbus Pharmaceuticals Holdings, Inc.

Security class: Common Stock, par value $0.0001 per share
Shares / value: 157,316
Estimated value: $1,586,075
Report date: 07 Aug 2026
Price: $10.08
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

Corbus Pharmaceuticals Holdings, Inc.

Security class: Stock options (right to buy)
Shares / value: 150,000
Estimated value
Report date: 14 Jan 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Insider Reports Filed by Yuval Cohen

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 07 Aug 2026
Transactions: 1
Transaction value: -$171,396
Accepted by SEC: 10 Aug 2026, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 13 Feb 2026
Transactions: 1
Transaction value: -$107,952
Accepted by SEC: 18 Feb 2026, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 14 Jan 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 16 Jan 2026, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 24 Oct 2025
Transactions: 6
Transaction value: -$353,487
Accepted by SEC: 27 Oct 2025, 16:23
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 14 Feb 2025
Transactions: 1
Transaction value: -$62,465
Accepted by SEC: 18 Feb 2025, 17:40
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 31 Jan 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 04 Feb 2025, 17:11
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 14 Jun 2024
Transactions: 22
Transaction value: -$1,987,632
Accepted by SEC: 18 Jun 2024, 17:58
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 12 Feb 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 14 Feb 2024, 15:19
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 26 Jan 2024
Transactions: 2
Transaction value: $0
Accepted by SEC: 30 Jan 2024, 16:56
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 10 Aug 2022
Transactions: 1
Transaction value: +$1,003
Accepted by SEC: 11 Aug 2022, 09:55
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 16 May 2022
Transactions: 1
Transaction value: +$2,625
Accepted by SEC: 16 May 2022, 10:41
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 09 Mar 2022
Transactions: 1
Transaction value: +$3,182
Accepted by SEC: 09 Mar 2022, 09:37
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 13 Feb 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 15 Feb 2023, 11:44
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRBP

Corbus Pharmaceuticals Holdings, Inc.

Report period: 01 Feb 2022
Transactions: 1
Transaction value: $0
Accepted by SEC: 02 Feb 2022, 16:51
Role: Chief Executive Officer, Director
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .